Archive

Obesity associated with more severe disease flares in early rheumatoid arthritis

Written by | 29 Nov 2023

Obesity is associated with worse flare symptoms and worse quality of life among patients with early rheumatoid arthritis, researchers reported on Nov. 12, 2023 at ACR Convergence 2023, […]

Managing anxiety and depression in arthritis

Written by | 5 Jun 2023

Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and […]

New breakthrough in the treatment of rheumatoid arthritis

Written by | 3 Feb 2023

A research team, led by Professor Sung Ho Park in the Department of Biological Sciences at UNIST announced the results of a study on osteoblasts that damage joint bones […]

One in five patients with rheumatoid arthritis were undiagnosed during the pandemic

Written by | 6 Nov 2022

The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests. The study, published today in The Lancet […]

Findings support repurposing rheumatoid arthritis drug auranofin for diabetes

Written by | 20 Oct 2022

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was […]

Older adults with rheumatoid arthritis still undermedicated, despite aggressive guidelines

Written by | 27 May 2022

Despite guidelines that call for early and aggressive treatment of rheumatoid arthritis, a new study suggests many older adults are not prescribed disease-modifying medications for their inflammatory autoimmune […]

Rheumatoid arthritis drug cuts mortality among COVID-19 ventilated patients

Written by | 19 Feb 2022

Critically ill COVID-19 patients already on mechanical ventilation or extracorporeal membrane oxygenation have achieved a significantly higher rate of survival when randomized to receive baricitinib, a treatment for […]

New EULAR consensus on prevention trials in people at risk of developing RA

Written by | 27 Oct 2021

RA is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It can also cause fatigue, and the underlying inflammation may affect other body […]

Parental smoking may increase children’s risk of developing rheumatoid arthritis

Written by | 16 Oct 2021

New research published in Arthritis & Rheumatology links parental smoking with an elevated risk of rheumatoid arthritis in children when they reach adulthood. Among 90,923 participants in the Nurses’ Health […]

Comorbidities and RA – study methodology

Written by | 9 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases to controls with similar medical histories. The […]

Implications of findings in comorbidities of RA

Written by | 8 Jan 2021

The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications for practice, according to lead researcher Dr […]

Comorbidities and RA – study findings

Written by | 7 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr Mark Tatangelo, the lead researcher explains. This study […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.